MAPT and Alzheimer disease: For AD development, it is commonly believed that the pathologically accumulated cellular products (Aβ, p-tau, proinflammatory molecules) cause neuronal and synaptic degeneration (i.e., according to the amyloid, tau and chronic inflammation hypotheses) [27,54].